CLYMCLYMNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.2%
5Y CAGR+38.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+21.2%/yr
Annual compound
5Y CAGR
+38.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$46.71M+225.8%
2024$14.34M-7.0%
2023$15.41M-41.2%
2022$26.21M+12.4%
2021$23.32M+149.6%
2020$9.34M+132.4%
2019$4.02M-